2011 Annual Meeting | Cumulative Sports Concussion and Risk of Dementia

Date Friday 04/15/11

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Barry D. Jordan, MD

Topic(s) Critical Care

Learning Objectives Participants should be able to recognize the neurological consequences of repetitive sports concussion in the athlete, along with an understanding of the magnitude of the problem and risk factors associated with chronic traumatic encephalopathy (CTE). Participants should be able identify radiological features of CTE utilizing more advanced neuroimaging techniques and understand the key pathological features of the syndrome. Furthermore, attendees will be able recognize the similarities between CTE and other neurodegenerative diseases while realizing that this syndrome may represent a distinct neurodegenerative process.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:50 PM		Clinical, Genetic, and Radiological Aspects of Cumulative Sports Concussion Barry D. Jordan, MD
01:50 PM - 02:40 PM		Pathological Features of Chronic Traumatic Encephalopathy in Athletes Ann C. McKee, MD
02:40 PM - 03:00 PM		Break
03:00 PM - 03:50 PM		The Problem of Neurodegeneration in Cumulative Sports Concussion: Emphasis on Neurofibrillary Tangle Formation Vassilis E. Koliatsos, MD
03:50 PM - 04:40 PM		Amyloid Deposition and Neurodegeneration Following Traumatic Brain Injury Douglas M. Smith, MD
04:40 PM - 05:00 PM		Discussion

Faculty Disclosures
Barry D. Jordan, MD	Dr. Jordan has nothing to disclose.
Ann C. McKee, MD	Dr. McKee has nothing to disclose.
Douglas M. Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pyros Pharma. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher-Smith. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Vassilis E. Koliatsos, MD	No disclosure on file

��ɫ��

��ɫ��